Cpi Igg Ab

ELISA kit for Pig Antibody against Foot and Mouth Disease IgG (FMDV-Ab-IgG)

KTE80190-48T 48T
EUR 464.4
Description: Quantitative sandwich ELISA for measuring Pig Antibody against Foot and Mouth Disease IgG (FMDV-Ab-IgG) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Igg Antibody Laboratories manufactures the cpi igg ab reagents distributed by Genprice. The Cpi Igg Ab reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igg antibody. Other Cpi products are available in stock. Specificity: Cpi Category: Igg Group: Ab

Human Legionella antibody IgG(LP Ab-IgG)ELISA Kit

96T
EUR 559.2

Human Brucella Antibody IgG(Brucella Ab IgG)ELISA Kit

48T
EUR 346.8

Human Brucella Antibody IgG(Brucella Ab IgG)ELISA Kit

96T
EUR 559.2

Human tuberculosis antibody IgG(TB-Ab IgG)ELISA Kit

48T
EUR 346.8

Human tuberculosis antibody IgG(TB-Ab IgG)ELISA Kit

96T
EUR 559.2

Human Legionella antibody IgG(LP Ab-IgG)ELISA Kit

96T
EUR 472.8

Human tuberculosis antibody IgG(TB-Ab IgG)ELISA Kit

96T
EUR 433.2

Ab information

CPI-203

B1081-5 5 mg
EUR 439.2
Description: CPI-203 is a potent, selectivie and competitive small molecule inhibitor of BET bromodomain with a mean GI50 value of 0.23?M in MCL cell lines [1].As an inhibitor of BET proteins, CPI-203 inhibits BRD4 in vitro and in cells.

CPI-455

B1881-25 each
EUR 705.6

CPI-455

B1881-5 each
EUR 222

CPI-169

B4678-10 10 mg
EUR 324
Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2).

CPI-169

B4678-100 100 mg
EUR 1730.4
Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2).

CPI-169

B4678-5 5 mg
EUR 247.2
Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2).

CPI-169

B4678-5.1 10 mM (in 1mL DMSO)
EUR 626.4
Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2).

CPI-169

B4678-50 50 mg
EUR 1027.2
Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2).

CPI-360

B4836-1 1 mg
EUR 151.2

CPI-360

B4836-10 10 mg
EUR 640.8

CPI-360

B4836-5 5 mg
EUR 374.4

CPI-637

B7801-10 10 mg
EUR 201.6
Description: IC50: 0.03 and 11.0 ?M for CBP/EP300 and BRD4, respectively.CPI-637 is a CBP/EP300 bromodomain inhibitor.

CPI-637

B7801-50 50 mg
EUR 543.6
Description: IC50: 0.03 and 11.0 ?M for CBP/EP300 and BRD4, respectively.CPI-637 is a CBP/EP300 bromodomain inhibitor.

CPI-455

B7811-25 25 mg
EUR 543.6
Description: IC50: 10 nMCPI-455 is a KDM5 inhibitor.The KDM5 family of histone demethylases catalyzes the demethylation of histone H3 on lysine 4 (H3K4) and is required for the survival of drug-tolerant persister cancer cells (DTPs).

CPI-455

B7811-5 5 mg
EUR 201.6
Description: IC50: 10 nMCPI-455 is a KDM5 inhibitor.The KDM5 family of histone demethylases catalyzes the demethylation of histone H3 on lysine 4 (H3K4) and is required for the survival of drug-tolerant persister cancer cells (DTPs).

CPI-455

HY-100421 5mg
EUR 207.6

CPI-637

HY-100482 100mg
EUR 1250.4